The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity. - Wikidata - wikimedia - TriplyDB

The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.

The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.

http://www.wikidata.org/entity/Q42234561

about

Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients.A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.α-1-Antitrypsin (AAT)-modified donor cells suppress GVHD but enhance the GVL effect: a role for mitochondrial bioenergetics.Therapy with plasma purified alpha1-antitrypsin (Prolastin®) induces time-dependent changes in plasma levels of MMP-9 and MPO.α1-Antitrypsin activates protein phosphatase 2A to counter lung inflammatory responses.Novel aspects of pathogenesis and regeneration mechanisms in COPD Alpha 1 Antitrypsin Inhibits Dendritic Cell Activation and Attenuates Nephritis in a Mouse Model of Lupus.Peptides from American alligator plasma are antimicrobial against multi-drug resistant bacterial pathogens including Acinetobacter baumannii.The rs361525 polymorphism does not increase production of tumor necrosis factor alpha by monocytes from alpha-1 antitrypsin deficient subjects with chronic obstructive pulmonary disease - a pilot study.Pulse of inflammatory proteins in the pregnant uterus of European polecats (Mustela putorius) leading to the time of implantation Immune-modulating effects of alpha-1 antitrypsin.Current status of gene therapy for α-1 antitrypsin deficiency.The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.The multiple facets of alpha-1-antitrypsin.Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update.Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency.Neutrophil Fates in Bronchiectasis and Alpha-1 Antitrypsin Deficiency.Alpha-1 Antitrypsin Deficiency: Beyond the Protease/Antiprotease Paradigm.Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.Th17 profile in COPD exacerbations.Brief Report: Genetic Variation of the α1 -Antitrypsin Gene Is Associated With Increased Autoantibody Production in Rheumatoid Arthritis.C-Terminal Alpha-1 Antitrypsin Peptide: A New Sepsis Biomarker with Immunomodulatory Function.Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.Alpha-1 antitrypsin augmentation therapy decreases miR-199a-5p, miR-598 and miR-320a expression in monocytes via inhibition of NFκB.Alpha-1 antitrypsin and granulocyte colony-stimulating factor as serum biomarkers of disease severity in ulcerative colitis.BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.Therapeutics: Alpha-1 Antitrypsin Augmentation Therapy.The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.α1-Antitrypsin deficiency.Neutrophilic panniculitis and autoinflammation: what's the link?: reply from authors.Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions.Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.Excessive Neutrophil Activity in Gestational Diabetes Mellitus: Could It Contribute to the Development of Preeclampsia?Phospholipid transfer protein and alpha-1 antitrypsin regulate Hck kinase activity during neutrophil degranulation

P2860

Q26858837-7A6D96D7-8D3D-40E7-B943-D41E9C02AD3F Q33568562-FF6DAE13-922D-4D94-ABA7-1464FA52524A Q34047949-73E0E466-AAE0-4028-BB3B-10EF9E9F5D86 Q34428735-19347227-0F9B-4CE1-B054-359584C4C722 Q34431458-34CDD061-09B6-4D7D-99CA-C592538627BF Q35031693-B8898F19-5158-4310-B6C8-28F0799B8B3C Q35044708-5EC52EC6-6784-45F1-8054-C63835ADE7D5 Q35665638-90BE6140-572B-428D-BA13-33944B95A0B6 Q36032325-80ED826C-EE2D-41AA-B3DC-D451DB141EB9 Q36108116-152A3C92-FE6F-4A5D-B02D-677658370D2E Q36336165-ECEF8F3E-5151-486B-AB50-F149B174109A Q36345517-1915BB99-E866-4AE4-ADCE-E3A360B69A3A Q38214040-C94A2EB6-5040-41F7-BCDD-C1ED671C3D4A Q38264336-7F7915AF-9DED-4A42-ACAE-B034E4C668D9 Q38322575-E527420C-CB68-4D6F-A8B7-698921C1F2BD Q38553419-3988AB8D-0548-4BF2-A17D-5ED3F41FD0C1 Q38581002-C2153195-DD3A-403D-A24D-678B1A645204 Q38643507-74B8C09B-7591-4DEB-90DE-3F76F8E6EC84 Q38711081-4D94396B-9517-4889-A905-B06E02FD33D3 Q38837735-929D9668-B780-469C-87C4-C4285809FC51 Q38875787-221FE7FF-1130-4C9F-B483-6EF6CB59273B Q38937849-B24BCF01-E5EC-410C-8322-9A0EDE3144C4 Q38937862-7D75B7E7-A5B7-41BB-A663-CA2DA8C367B1 Q39426939-79E40817-D473-49B5-8FE0-EA8763A2BD47 Q40242438-9A537009-FF1B-4210-A207-73AA84E1B9E8 Q40624050-CCA6B459-D03C-4248-9B9D-ECE254407E74 Q41402538-A93FC891-81A1-46F2-9560-29A45A353535 Q42924805-04FAF65D-DC10-4AD7-8114-0A0FFAAADE96 Q43551236-0E5730F5-0102-4588-8F24-8DDB5C5EB36B Q47105853-FC5CA6C2-8C75-4C74-AD8A-677E3258FDD9 Q47703811-8DB65ED1-37B9-444E-824F-A757ED90618D Q51465407-00A9275E-6FCA-422B-A447-AD45FF47DCC5 Q51481224-8B1221DA-D68C-43B1-8B51-0D6B61650147 Q51481619-780A28AB-C766-4BD6-AB37-69065D987E85 Q51568269-570BFBFD-A6B5-405D-A435-A7F511CAC9D9 Q55011363-039EAF4E-6DC2-4131-9E7C-7DDE17269E6A Q55259593-D699F1B8-177A-4D0F-AC68-F8F149302A8E Q55438350-6F7D873A-8447-4A43-983D-1DF56FEA9726 Q57300007-4172B097-C99B-4C0E-80EF-C0B73FEB00D3 Q58603381-AE0424AE-9DD2-43F5-838F-8FEACF6B85C1

P2860

The circulating proteinase inhibitor α-1 antitrypsin regulates neutrophil degranulation and autoimmunity.

http://www.wikidata.org/entity/Q42234561

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

The circulating proteinase inh ...... egranulation and autoimmunity.

@en

The circulating proteinase inh ...... egranulation and autoimmunity.

@nl

type

label

The circulating proteinase inh ...... egranulation and autoimmunity.

@en

The circulating proteinase inh ...... egranulation and autoimmunity.

@nl

prefLabel

The circulating proteinase inh ...... egranulation and autoimmunity.

@en

The circulating proteinase inh ...... egranulation and autoimmunity.

@nl

P1433

Q42234561-85F22986-8288-4C6B-843E-4CECD3EDB7E4

P1476

Q42234561-B12110F3-CDF0-403F-959B-0C8F8BA0CA16

P2093

Q42234561-0F8156A8-571A-49D9-96F0-3632945C9195

Q42234561-19CC9A58-2C3D-4CE2-A9AF-EA314DE3F01B

Q42234561-2ACE87F7-A668-4617-AFCB-D6305A3C8CD9

Q42234561-B23281AB-0C19-42B6-A8E4-51357DCAD1F2

Q42234561-D88F2598-C3EF-4E5F-9365-C014F4B43BB7

Q42234561-E4583272-F5A5-4DB4-9167-BB423F52B99D

P2860

Q42234561-001202F5-6BB0-4534-B35D-7CDA24505DCE

Q42234561-00700ABD-9BDF-4D92-95FF-CC458A5800BC

Q42234561-0AFF95CF-3AA8-4A92-91CB-B4790B32A68E

Q42234561-0B75B65E-CDC8-463E-8807-8694B10DE240

Q42234561-0C75A650-FD39-4D89-A607-F33BCEF64F8C

Q42234561-0F33611C-F3E3-4D35-9B80-63C774380046

Q42234561-1CF1E133-BCD7-479E-BCFE-EA1A29FD4543

Q42234561-24C15DD8-5829-488A-B70B-B0A4C83BE756

Q42234561-266ED672-E045-4E1C-BA6F-272927DBE9E3

Q42234561-2C3C24A6-8BB9-4437-B8B2-40AAC43F0C1C

P304

Q42234561-06D67AB6-4E8E-4446-8CA2-D64901EDB28D

P31

Q42234561-06D2F285-7571-4D9E-89BC-C130E4198BF3

P356

Q42234561-BF42F797-1717-4533-A5E5-413B4A7BFABF

P407

Q42234561-C28F6A3E-7C17-4B0F-BEBE-809124073F1B

P433

Q42234561-5D8A8277-6EED-45D6-8CAD-974176847DCF

P478

Q42234561-A0317A9D-1C03-4001-BF57-1922B3A3F437

P50

Q42234561-60024462-BA78-4BD2-8EC6-ED8B966EC1FD

P577

Q42234561-A1D13901-DAA1-45EE-8C56-76ED4F907C22

P698

Q42234561-6402B197-821F-44DC-B6AB-31FB8FC29BE5

P356

SCITRANSLMED.3007116

P1433

Science Translational Medicine

P1476

The circulating proteinase inh ...... degranulation and autoimmunity

@en

P2093

David A Bergin

http://www.w3.org/2001/XMLSchema#string

Emer P Reeves

http://www.w3.org/2001/XMLSchema#string

Noel G McElvaney

http://www.w3.org/2001/XMLSchema#string

Ramia Jameel

http://www.w3.org/2001/XMLSchema#string

Rebecca Wolfe

http://www.w3.org/2001/XMLSchema#string

Sean Fitzgerald

http://www.w3.org/2001/XMLSchema#string

P2860

SP-A binds alpha1-antitrypsin in vitro and reduces the association rate constant for neutrophil elastase.

Alpha 1-antitrypsin binds to and interferes with functionality of EspB from atypical and typical enteropathogenic Escherichia coli strains

α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide

Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide

Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3

Proteomic analysis of human neutrophil granules

The protease inhibitor PI*S allele and COPD: a meta-analysis

Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor

P304

217ra1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1126/SCITRANSLMED.3007116

http://www.w3.org/2001/XMLSchema#string

P407

P433

217

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24382893

http://www.w3.org/2001/XMLSchema#string